Biologics have revolutionized – and are revolutionizing – the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days’ exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics. Yet concerns persist about biosimilars – particularly in curative cancer treatment, where they are relatively recent therapeutic options. ‘Fast Facts: Biosimilars in Hematology and Oncology’ provides a concise overview of emerging global practice in this fast-moving area together with practical information on adding biosimilars to a formulary and switching patients.
قم بشراء هذا الكتاب الإلكتروني واحصل على كتاب آخر مجانًا!
لغة الإنجليزية ● شكل EPUB ● صفحات 128 ● ISBN 9781912776221 ● حجم الملف 5.5 MB ● الناشر S. Karger AG ● مدينة Basel ● بلد CH ● نشرت 2020 ● الإصدار 1 ● للتحميل 24 الشهور ● دقة EUR ● هوية شخصية 7729225 ● حماية النسخ Adobe DRM
يتطلب قارئ الكتاب الاليكتروني قادرة DRM